Ultrasound Changes in Sjögren's Syndrome: Temporal Stability
Parotid gland changes on ultrasound in Sjögren's syndrome generally remain stable over time, with the majority of patients (approximately 79%) showing no significant change over a 2-year period.
Evidence for Stability of Ultrasound Findings
The most robust longitudinal data demonstrates that salivary gland ultrasound (SGUS) abnormalities are relatively static in established Sjögren's syndrome:
In a 2-year follow-up study of 70 patients with primary Sjögren's syndrome, 78.6% showed stable SGUS scores, while only 18.6% worsened and 2.9% improved 1
A separate cohort study with mean follow-up of 1.9 years found that SGUS abnormalities assessed using semi-quantitative scoring (0-4 scale) did not change significantly during follow-up in patients with established Sjögren's syndrome 2
The median change in total SGUS scores was minimal (+1.0 for total glands, +0.5 for parotid glands specifically) over approximately 23 months 1
Specific Ultrasound Features and Their Behavior
Different ultrasound characteristics show varying patterns over time:
Homogeneity and hypoechoic areas showed statistically significant progression when changes did occur 1
Multiple hypoechoic areas (MHA) measuring 2-5 mm in diameter, which represent enlarged parotid lobules replaced by lymphocytic infiltration, are characteristic findings in intermediate-stage disease 3
Follow-up ultrasound in one older study showed MHA appearing in one patient, reduction in nonhomogeneity in three patients, and no interval changes in the remaining cases 3
Predictors of Progression
When ultrasound changes do worsen, specific features are associated with progression:
Intraglandular power Doppler signal (PDS) indicating hypervascularity was significantly higher at baseline in patients whose SGUS scores subsequently worsened 1
Patients with evidence of active inflammation (increased vascularity) appear more likely to show structural progression over time 1
Clinical Implications
The relative stability of ultrasound findings has important implications:
SGUS abnormalities appear to reflect established structural damage rather than fluctuating inflammatory activity 2
The EULAR guidelines note that future clinical trials might benefit from including patients with "early salivary gland ultrasound changes" before permanent damage is established, suggesting that early changes may be more reversible than late findings 4
The distinction between early reversible changes and late irreversible damage is critical, as the guidelines emphasize identifying patients "before permanent damage has been established and the changes are still reversible" 4
Common Pitfalls to Avoid
Do not assume that stable ultrasound findings indicate inactive disease - systemic manifestations may progress independently of glandular structural changes 1
Do not use ultrasound alone to monitor treatment response in systemic disease - the EULAR guidelines emphasize using disease activity indices like ESSDAI for systemic involvement 4
Be aware that the presence of power Doppler signal suggests ongoing inflammatory activity that may warrant closer monitoring, even if structural scores remain stable 1